Primagen Holding B.V. Validates Use Of Dry Filter Spot (DFS) HIV-1 Testing Service With Roche (RHHBY) COBAS AMPLICOR(R) HIV-1 Test
6/14/2006 12:27:45 PM
More...
|
Primagen Holding B.V. Announces New Clinical Research Services For Angiogenesis And Free-Circulating DNA And RNA Cancer Biomarkers At American Society of Clinical Oncology
5/24/2006 10:37:41 AM
More...
|
Primagen Holding B.V. Expands Into Cardiovascular Field With Technology License From The University of Texas M. D. Anderson Cancer Center
4/25/2006 10:32:50 AM
More...
|
Primagen Holding B.V. Awarded U.S. Patent For Using Mitochondrial DNA Quantification As Biomarker
4/18/2006 12:37:19 PM
More...
|
Primagen Holding B.V. Virus Discovery Group Chosen For EU-Funded GRACE Network Of Excellence
3/28/2006 12:12:24 PM
More...
|
Primagen Holding B.V. Announces An Upgrade Of Their Dry Filter Spot (DFS) HIV-1 Testing Service For Resource Poor Settings With The Addition Of The Roche (RHHBY) COBAS AMPLICOR(R) HIV-1 Test v1.5
2/8/2006 12:57:56 PM
More...
|
Primagen Holding B.V. Licenses Newly Discovered Coronavirus CoV-NL63 To bioMerieux, Inc.
2/1/2006 12:59:06 PM
More...
|
Primagen Holding B.V. And Roche Molecular Systems, Inc. (RHHBF.PK) Initiate Discussions To Develop Dry Filter Spot Technology For HIV-1 Viral Load Testing In The Developing World
10/19/2005 5:13:20 PM
More...
|
Primagen Holding B.V. Receives "Notice Of Allowance" From The US Patent And Trademark Office
10/19/2005 5:12:28 PM
More...
|
Primagen Holding B.V. Announces Appointment Of President For Its US Subsidiary, Primagen Inc.
10/19/2005 5:12:00 PM
More...
|
|